Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Haas

Showing results (751-760 of 822) with videos related to

Pageof 83
Sort By:
American Journal of Preventive Medicine|May 3, 2016
Follow-Up of Abnormal Breast and Colorectal Cancer Screening by Race/EthnicityAnne Marie McCarthy, Jane J Kim, Elisabeth F Beaber, et al.
Contemporary Clinical Trials|August 10, 2021
Multilevel Follow-up of Cancer Screening (mFOCUS): Protocol for a multilevel intervention to improve the follow-up of abnormal cancer screening test resultsJennifer S Haas, Steven J Atlas, Adam Wright, et al.
European Archives of Psychiatry and Clinical Neuroscience|September 18, 2021
The clinical relevance of formal thought disorder in the early stages of psychosis: results from the PRONIA studyOemer Faruk Oeztuerk, Alessandro Pigoni, Julian Wenzel, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 22, 2023
Transdiagnostic subgroups of cognitive impairment in early affective and psychotic illnessJulian Wenzel, Luzie Badde, Shalaila S Haas, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 2, 2022
Evaluating and Improving Cancer Screening Process Quality in a Multilevel Context: The PROSPR II Consortium Design and Research AgendaElisabeth F Beaber, Aruna Kamineni, Andrea N Burnett-Hartman, et al.
JAMA Internal Medicine|April 27, 2026
Mailed Outreach for Colorectal Cancer Screening in Community Health Centers: The CARES Pragmatic Cluster Randomized Clinical TrialFolasade P May, Suzanne Brodney, Jessica J Tuan, et al.
Translational Psychiatry|May 25, 2021
Multimodal prognosis of negative symptom severity in individuals at increased risk of developing psychosisDaniel J Hauke, André Schmidt, Erich Studerus, et al.
The Lancet. Digital Health|February 23, 2024
Normative modelling of brain morphometry across the lifespan with CentileBrain: algorithm benchmarking and model optimisationRuiyang Ge, Yuetong Yu, Yi Xuan Qi, et al.
Biological Psychiatry. Cognitive Neuroscience and Neuroimaging|June 21, 2023
Structural and Functional Brain Patterns Predict Formal Thought Disorder's Severity and Its Persistence in Recent-Onset Psychosis: Results From the PRONIA StudyMadalina-Octavia Buciuman, Oemer Faruk Oeztuerk, David Popovic, et al.
Journal of the National Cancer Institute|July 12, 2019
Evaluating Screening Participation, Follow-up, and Outcomes for Breast, Cervical, and Colorectal Cancer in the PROSPR ConsortiumWilliam E Barlow, Elisabeth F Beaber, Berta M Geller, et al.
Pageof 83

Showing results (751-760 of 822) with videos related to

Sort By:
Pageof 83
American Journal of Preventive Medicine|May 3, 2016
Follow-Up of Abnormal Breast and Colorectal Cancer Screening by Race/EthnicityAnne Marie McCarthy, Jane J Kim, Elisabeth F Beaber, et al.
Contemporary Clinical Trials|August 10, 2021
Multilevel Follow-up of Cancer Screening (mFOCUS): Protocol for a multilevel intervention to improve the follow-up of abnormal cancer screening test resultsJennifer S Haas, Steven J Atlas, Adam Wright, et al.
European Archives of Psychiatry and Clinical Neuroscience|September 18, 2021
The clinical relevance of formal thought disorder in the early stages of psychosis: results from the PRONIA studyOemer Faruk Oeztuerk, Alessandro Pigoni, Julian Wenzel, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 22, 2023
Transdiagnostic subgroups of cognitive impairment in early affective and psychotic illnessJulian Wenzel, Luzie Badde, Shalaila S Haas, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 2, 2022
Evaluating and Improving Cancer Screening Process Quality in a Multilevel Context: The PROSPR II Consortium Design and Research AgendaElisabeth F Beaber, Aruna Kamineni, Andrea N Burnett-Hartman, et al.
JAMA Internal Medicine|April 27, 2026
Mailed Outreach for Colorectal Cancer Screening in Community Health Centers: The CARES Pragmatic Cluster Randomized Clinical TrialFolasade P May, Suzanne Brodney, Jessica J Tuan, et al.
Translational Psychiatry|May 25, 2021
Multimodal prognosis of negative symptom severity in individuals at increased risk of developing psychosisDaniel J Hauke, André Schmidt, Erich Studerus, et al.
The Lancet. Digital Health|February 23, 2024
Normative modelling of brain morphometry across the lifespan with CentileBrain: algorithm benchmarking and model optimisationRuiyang Ge, Yuetong Yu, Yi Xuan Qi, et al.
Biological Psychiatry. Cognitive Neuroscience and Neuroimaging|June 21, 2023
Structural and Functional Brain Patterns Predict Formal Thought Disorder's Severity and Its Persistence in Recent-Onset Psychosis: Results From the PRONIA StudyMadalina-Octavia Buciuman, Oemer Faruk Oeztuerk, David Popovic, et al.
Journal of the National Cancer Institute|July 12, 2019
Evaluating Screening Participation, Follow-up, and Outcomes for Breast, Cervical, and Colorectal Cancer in the PROSPR ConsortiumWilliam E Barlow, Elisabeth F Beaber, Berta M Geller, et al.
Pageof 83